Venetoclax/Obinutuzumab Effective in CLL

A study shows bendamustine followed by venetoclax and obinutuzumab was active in treatment-naive or relapsed/refractory CLL.

Source: CancerNetwork - September 5, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news